Diagnosis Annotation Services for Clinical AI, Imaging Models, and Decision Support Systems

Diagnosis annotation labels medical imaging data specifically for AI-assisted diagnostic systems: flagging and characterizing diagnostic findings, lesions, and pathological regions that clinicians use to make diagnostic decisions. It includes marking the presence and location of abnormalities (tumors, calcifications, fractures, effusions, lesions), characterizing their properties (size, shape, margins, density, enhancement pattern), assigning Likert-scale severity or confidence ratings, and annotating differential diagnosis categories. Unlike general medical segmentation annotation, diagnosis annotation is specifically designed to train systems that support clinical decision-making.

Diagnosis annotation requires licensed physicians with the relevant specialty training as annotators or reviewers. Radiologists for CT, MRI, and X-ray annotation. Pathologists for histopathology annotation. Ophthalmologists for retinal imaging annotation. Dermatologists for skin lesion annotation. This is non-negotiable for two reasons. First, diagnostic accuracy requires clinical knowledge that even highly trained non-physicians cannot provide: the subtle imaging features that distinguish a malignant from a benign lesion require years of clinical training to recognize reliably. Second, regulatory submissions for clinical AI typically require demonstration that training data was created by qualified clinicians, which makes annotator credentials part of the compliance documentation.

Diagnosis annotation quality is typically measured with clinical-grade metrics. For segmentation tasks, Dice Similarity Coefficient (DSC) above 0.85 is typically required for clinical-grade datasets, with some applications requiring 0.90 or above. For classification tasks, Fleiss kappa above 0.75 is typical. For the most critical applications (cancer detection, stroke diagnosis), multiple board-certified specialists annotate each case independently, and adjudication by a senior specialist resolves disagreements. The adjudication process is itself documented, because the adjudication decision rather than any individual annotation represents the dataset's ground truth for difficult cases.

AI-assisted diagnostic systems typically fall within the medical device regulatory framework. In Europe, AI systems used as medical devices require CE marking under the Medical Device Regulation (MDR) or In Vitro Diagnostic Regulation (IVDR), and AI-powered diagnostic support tools embedded in medical devices are additionally high-risk under the EU AI Act Annex I. This means training data documentation must satisfy both MDR/IVDR clinical evidence requirements and EU AI Act Article 10 data governance requirements. Annotation methodology, annotator qualifications (including specialization and board certification status), inter-annotator agreement metrics, and dataset coverage evidence are all part of the required documentation.

Diagnosis annotation datasets are subject to the strictest privacy and ethical standards of any annotation category. Patient data is special category personal data under GDPR. Datasets created from clinical practice require either explicit patient consent for AI research use or pseudonymization meeting GDPR standards. Ethics committee approval is typically required for research annotation programs using patient data. Institutional data sharing agreements govern cross-institutional annotation programs. DataVLab works within these frameworks for diagnosis annotation projects, including EU-based processing under GDPR-compliant protocols and coordination with institutional ethics requirements.

DataVLab provides diagnosis annotation across radiology (CT, MRI, X-ray, PET for oncology, neurology, musculoskeletal, and cardiac applications), pathology (whole slide imaging for cancer grading, tumor characterization, and biomarker identification), ophthalmology (fundus photography and OCR for diabetic retinopathy, glaucoma, and AMD staging), and dermatology (dermoscopy for melanoma detection and skin lesion classification). We work with medical AI companies, diagnostic imaging AI developers, hospital digital health programs, and clinical research organizations. All diagnosis annotation programs use licensed specialists for annotation and review, with inter-annotator agreement documentation for regulatory submissions.